Locust Walk Acquisition Corp.
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $175.00M |
|---|---|
| IPO Date | Jan 8, 2021 |
| CEO | Chris Ehrlich |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | eFFECTOR Therapeutics |
| Deal Announced | May 27, 2021 |
| Deal Size, $M | $419.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Aug 24, 2021 |
| Amendment Vote | TBD |
| Closing Date | Aug 25, 2021 |
Formerly LWAC
EFTR
EFTRW
| Price | $0.00 $0.00 |
|---|---|
| Last closing price | $0.18 |
| H/L, today | $0.00 / $0.00 |
| H/L, 52-week | $0.34 / $1.48 |
| Volume, today | 63 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.